echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hengrui Medicine's HR19003 patch was approved for clinical use

    Hengrui Medicine's HR19003 patch was approved for clinical use

    • Last Update: 2021-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 5, Hengrui Pharmaceuticals issued an announcement stating that the company has recently received the "Notice of Drug Clinical Trial Approval" for the HR19003 patch approved by the National Medical Products Administration, agreeing to use this product for post-herpetic neuralgia.


    Shingles is a cluster of herpes distributed along the nerves caused by varicella-zoster virus infection


    This product can penetrate the skin around the peripheral nerves of the medication site, block the sodium ion channel on the nerve cell membrane, inhibit the flow of sodium ions into the nerve fiber cell membrane, block nerve excitement and conduction, and produce reversible local block, thereby achieving analgesia and anesthesia The effect


    After inquiring the EvaluatePharma database, Lidoderm®'s global sales in 2020 are approximately US$345 million, and Ztlido®'s global sales in 2020 are approximately US$26 million.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.